Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
NCT ID:
NCT01006369
Group ID:
EG000
Title:
FOLFOX6 + Bevacizumab + Hydroxychloroquine
Description:
bevacizumab: Arm A: FOLFOX6 + Bevacizumab + Hydroxychloroquine: Bevacizumab will be administered intravenously 5 mg/kg in 100 cc Normal Saline every 14 days on day one
Arm B: XELOX + Bevacizumab + Hydroxychloroquine: Bevacizumab will be administered intravenously 7.5 mg/kg in 100 cc Normal Saline every 21 days
hydroxychloroquine: hydroxychloroquine 200 mg po BID daily
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
13
Other Number Affected:
13
Other Number At Risk:
13
Study:
NCT01006369
Results Section:
NCT01006369
Adverse Events Module:
NCT01006369